SCHEMBL17791079

SCHEMBL17791079

NS(=O)(=O)c1cccc(NC(=O)c2cc(Cl)c(Cl)cc2Oc2ccc(CO)cc2F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17791088 0.92 — —
SCHEMBL17791113 0.88 — —
SCHEMBL17791100 0.85 CA1 (0.51) —
SCHEMBL16408396 0.85 — —
SCHEMBL17791114 0.83 — —
SCHEMBL17791089 0.82 — —
SCHEMBL16408392 0.81 SCN8A (0.64) —
SCHEMBL16408241 0.81 — —
SCHEMBL17791067 0.81 — —
SCHEMBL16398704 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160152561-A1 SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2016-06-02 — — US disclosed
Send feedback